Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pearl Mingmu eye drops for visual fatigue
ChiCTR2100051594Phase 4Not yet recruiting
- Sponsor
- Changzhou Second People's Hospital
- Start
- Sep 2021
- Countries
- 1
01
Overview
Phase 4, open-label trial of pearl mingmu in asthenopia (2 arms), sponsored by Changzhou Second People's Hospital. Primary endpoints: Change in visual fatigue scale score from baseline and Change in corneal fluorescein staining score from baseline. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
pearl mingmu
03
Conditions
asthenopia
Beyond the preview
Go deeper on ChiCTR2100051594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051594.